866-997-4948(US-Canada Toll Free)

China Solid Tumors Drugs Market Research Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 112 Pages

Notes:
Sales, means the sales volume of Solid Tumors Drugs
Revenue, means the sales value of Solid Tumors Drugs

This report studies Solid Tumors Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Hoffmann-La Roche
Novartis
Celgene
Johnson & Johnson
Pfizer
BMS
AbbVie
AbGenomics
ADC Therapeutics
TG Therapeutics
Polaris Pharmaceuticals
Immunogen
CTI BioPharma
Chugai Pharmaceutical
NewLink Genetics

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by Application, this report focuses on consumption, market share and growth rate of Solid Tumors Drugs in each application, can be divided into
Application 1
Application 2

Table of Contents

China Solid Tumors Drugs Market Research Report 2017
1 Solid Tumors Drugs Market Overview
1.1 Product Overview and Scope of Solid Tumors Drugs
1.2 Solid Tumors Drugs Segment by Type
1.2.1 China Production Market Share of Solid Tumors Drugs Type in 2015
1.2.2 Type I
1.2.3 Type II
1.3 Applications of Solid Tumors Drugs
1.3.1 Solid Tumors Drugs Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.4 China Market Size (Value) of Solid Tumors Drugs (2012-2022)
1.5 China Solid Tumors Drugs Status and Outlook
1.6 Government Policies

2 China Solid Tumors Drugs Market Competition by Manufacturers
2.1 China Solid Tumors Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Solid Tumors Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Solid Tumors Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Solid Tumors Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Solid Tumors Drugs Market Competitive Situation and Trends
2.5.1 Solid Tumors Drugs Market Concentration Rate
2.5.2 Solid Tumors Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Solid Tumors Drugs Manufacturers Profiles/Analysis
3.1 Hoffmann-La Roche
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Solid Tumors Drugs Product Type, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 Hoffmann-La Roche Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Novartis
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Solid Tumors Drugs Product Type, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Novartis Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Celgene
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Solid Tumors Drugs Product Type, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Celgene Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Johnson & Johnson
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Solid Tumors Drugs Product Type, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 Johnson & Johnson Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Pfizer
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Solid Tumors Drugs Product Type, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Pfizer Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 BMS
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Solid Tumors Drugs Product Type, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 BMS Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 AbbVie
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Solid Tumors Drugs Product Type, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 AbbVie Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 AbGenomics
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Solid Tumors Drugs Product Type, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 AbGenomics Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 ADC Therapeutics
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Solid Tumors Drugs Product Type, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 ADC Therapeutics Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 TG Therapeutics
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Solid Tumors Drugs Product Type, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 TG Therapeutics Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Polaris Pharmaceuticals
3.12 Immunogen
3.13 CTI BioPharma
3.14 Chugai Pharmaceutical
3.15 NewLink Genetics

4 China Solid Tumors Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Solid Tumors Drugs Capacity, Production and Growth (2012-2017)
4.2 China Solid Tumors Drugs Revenue and Growth (2012-2017)
4.3 China Solid Tumors Drugs Production, Consumption, Export and Import (2012-2017)

5 China Solid Tumors Drugs Production, Revenue (Value), Price Trend by Type
5.1 China Solid Tumors Drugs Production and Market Share by Type (2012-2017)
5.2 China Solid Tumors Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Solid Tumors Drugs Price by Type (2012-2017)
5.4 China Solid Tumors Drugs Production Growth by Type (2012-2017)

6 China Solid Tumors Drugs Market Analysis by Application
6.1 China Solid Tumors Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Solid Tumors Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaSolid Tumors Drugs Market Analysis by Regions (Provinces)
7.1 China Solid Tumors Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Solid Tumors Drugs Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Solid Tumors Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Solid Tumors Drugs Sales Price by Regions (Provinces)(2012-2017)
7.2 China Solid Tumors Drugs Consumption by Regions (Provinces)(2012-2017)
7.3 China Solid Tumors Drugs Production, Consumption, Export and Import (2012-2017)

8 Solid Tumors Drugs Manufacturing Cost Analysis
8.1 Solid Tumors Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Solid Tumors Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Solid Tumors Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Solid Tumors Drugs Market Forecast (2017-2022)
12.1 China Solid Tumors Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Solid Tumors Drugs Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Solid Tumors Drugs Production Forecast by Type (2017-2022)
12.4 China Solid Tumors Drugs Consumption Forecast by Application (2017-2022)
12.5 China Solid Tumors Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Solid Tumors Drugs Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Solid Tumors Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Solid Tumors Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Solid Tumors Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Solid Tumors Drugs
Figure China Production Market Share of Solid Tumors Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Table Solid Tumors Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure China Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table China Solid Tumors Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Solid Tumors Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Solid Tumors Drugs Capacity of Key Manufacturers in 2015
Figure China Solid Tumors Drugs Capacity of Key Manufacturers in 2016
Table China Solid Tumors Drugs Production of Key Manufacturers (2015 and 2016)
Table China Solid Tumors Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Solid Tumors Drugs Production Share by Manufacturers
Figure 2016 Solid Tumors Drugs Production Share by Manufacturers
Table China Solid Tumors Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Solid Tumors Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Solid Tumors Drugs Revenue Share by Manufacturers
Table 2016 China Solid Tumors Drugs Revenue Share by Manufacturers
Table China Market Solid Tumors Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Solid Tumors Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Solid Tumors Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Solid Tumors Drugs Product Type
Figure Solid Tumors Drugs Market Share of Top 3 Manufacturers
Figure Solid Tumors Drugs Market Share of Top 5 Manufacturers
Table Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hoffmann-La Roche Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Hoffmann-La Roche Solid Tumors Drugs Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Solid Tumors Drugs Market Share (2012-2017)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Celgene Solid Tumors Drugs Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Solid Tumors Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Solid Tumors Drugs Market Share (2012-2017)
Table BMS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BMS Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure BMS Solid Tumors Drugs Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Solid Tumors Drugs Market Share (2012-2017)
Table AbGenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbGenomics Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AbGenomics Solid Tumors Drugs Market Share (2012-2017)
Table ADC Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ADC Therapeutics Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure ADC Therapeutics Solid Tumors Drugs Market Share (2012-2017)
Table TG Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TG Therapeutics Solid Tumors Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure TG Therapeutics Solid Tumors Drugs Market Share (2012-2017)
Table Polaris Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Immunogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CTI BioPharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Chugai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NewLink Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Solid Tumors Drugs Capacity, Production and Growth (2012-2017)
Figure China Solid Tumors Drugs Revenue (Million USD) and Growth (2012-2017)
Table China Solid Tumors Drugs Production, Consumption, Export and Import (2012-2017)
Table China Solid Tumors Drugs Production by Type (2012-2017)
Table China Solid Tumors Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Solid Tumors Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Solid Tumors Drugs by Type
Table China Solid Tumors Drugs Revenue by Type (2012-2017)
Table China Solid Tumors Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Solid Tumors Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Solid Tumors Drugs by Type
Table China Solid Tumors Drugs Price by Type (2012-2017)
Figure China Solid Tumors Drugs Production Growth by Type (2012-2017)
Table China Solid Tumors Drugs Consumption by Application (2012-2017)
Table China Solid Tumors Drugs Consumption Market Share by Application (2012-2017)
Figure China Solid Tumors Drugs Consumption Market Share by Application in 2015
Table China Solid Tumors Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Solid Tumors Drugs Consumption Growth Rate by Application (2012-2017)
Table China Solid Tumors Drugs Production by Regions (Provinces)(2012-2017)
Table China Solid Tumors Drugs Production Market Share by Regions (Provinces)(2012-2017)
Table China Solid Tumors Drugs Production Value by Regions (Provinces)(2012-2017)
Table China Solid Tumors Drugs Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Solid Tumors Drugs Sales Price by Regions (Provinces)(2012-2017)
Table China Solid Tumors Drugs Consumption by Regions (Provinces)(2012-2017)
Table China Solid Tumors Drugs Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Solid Tumors Drugs Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Solid Tumors Drugs
Figure Manufacturing Process Analysis of Solid Tumors Drugs
Figure Solid Tumors Drugs Industrial Chain Analysis
Table Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
Table Major Buyers of Solid Tumors Drugs
Table Distributors/Traders List
Figure China Solid Tumors Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Solid Tumors Drugs Revenue and Growth Rate Forecast (2017-2022)
Table China Solid Tumors Drugs Production, Import, Export and Consumption Forecast (2017-2022)
Table China Solid Tumors Drugs Production Forecast by Type (2017-2022)
Table China Solid Tumors Drugs Consumption Forecast by Application (2017-2022)
Table China Solid Tumors Drugs Production Forecast by Regions (Provinces)(2017-2022)
Table China Solid Tumors Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Solid Tumors Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *